Neuraminidase Inhibitor Treatment for Influenza B-Related Pneumonia
Early neuraminidase inhibitor therapy may result in better outcomes in patients hospitalized with influenza B-related pneumonia.
All articles by Zahra Masoud
Pneumonia Mortality Not Improved With Empiric Anti-MRSA Therapy
Anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy in addition to standard pneumonia therapy does not improve mortality.
Antibiotic and Antiviral Combination to Treat Influenza
Compared with patients prescribed only an antiviral, patients who are prescribed both an antiviral and antibiotic have a lower risk for 3-day respiratory hospitalization.
Rifampicin May Be Safer Than Isoniazid in Latent Tuberculosis Treatment
In patients without a contraindication, rifampicin may be the safest treatment option for latent tuberculosis (TB) infection.
No Association Between Influenza Severity and Pediatric Vaccination Rate
Vaccine effectiveness and severity of current and prior seasons of influenza have demonstrated no association with vaccination rate in children, according to a study published in JAMA Pediatrics. Compared with other pediatric and adolescent vaccines, the influenza vaccination rate remains low in children. Although many reasons may affect whether a child is vaccinated, the extent…
M72/AS01 Tuberculosis Vaccine Remains Efficacious After 3 Years
The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years in patients with Mycobacterium tuberculosis infection.
Pneumococcal Vaccine Needed for Recipients of Solid Organ Transplant
Pneumococcal colonization rates are low in recipients of solid organ transplants, but most of the colonizing serotypes are not included in pneumococcal vaccines.
Rifampin and Isoniazid Is Efficacious in Treatment of Pleural Tuberculosis
As a result of low drug resistance in pleural tuberculosis, treatment regimens of pleural TB may include fewer drugs and maintain appropriate levels of efficaciousness.
High-Dose, Quadrivalent Influenza B Vaccine Is safe and Immunogenic
Compared with the standard-dose influenza vaccine, a high-dose quadrivalent inactivated influenza vaccine, GC3114, may provide a more effective influenza vaccine option for the elderly population.
Serotype Replacement in Childhood Invasive Pneumococcal Disease
Understanding the pneumococcal population dynamics will drive an effective next-generation vaccine design.
Next post in Pneumonia
